Differences in Vitreous Protein Profiles in Patients With Proliferative Diabetic Retinopathy Before and After Ranibizumab Treatment

Proliferative diabetic retinopathy (PDR) accounts for severe impact on vision, its mechanism is still poorly understood. To compare the differences of vitreous protein profiles in PDR patients before and after a complete anti-vascular endothelial growth factor (VEGF) loading dose with ranibizumab tr...

Descripción completa

Detalles Bibliográficos
Autores principales: She, Xinping, Zou, Chen, Zheng, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198965/
https://www.ncbi.nlm.nih.gov/pubmed/35721061
http://dx.doi.org/10.3389/fmed.2022.776855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198965/
https://www.ncbi.nlm.nih.gov/pubmed/35721061
http://dx.doi.org/10.3389/fmed.2022.776855

Ejemplares similares